Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Debt to Equity (2016 - 2026)

Nutex Health (NUTX) has disclosed Debt to Equity for 12 consecutive years, with $0.09 as the latest value for Q1 2026.

  • For Q1 2026, Debt to Equity fell 33.08% year-over-year to $0.09; the TTM value through Mar 2026 reached $0.09, down 33.08%, while the annual FY2025 figure was $0.1, 48.65% down from the prior year.
  • Debt to Equity hit $0.09 in Q1 2026 for Nutex Health, down from $0.1 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.47 in Q4 2023 and bottomed at $0.02 in Q1 2022.
  • Average Debt to Equity over 5 years is $0.23, with a median of $0.22 recorded in 2023.
  • Year-over-year, Debt to Equity soared 3886.2% in 2022 and then plummeted 81.37% in 2025.
  • Nutex Health's Debt to Equity stood at $0.3 in 2022, then skyrocketed by 58.63% to $0.47 in 2023, then tumbled by 58.34% to $0.2 in 2024, then plummeted by 48.65% to $0.1 in 2025, then decreased by 7.64% to $0.09 in 2026.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.09, $0.1, and $0.07 for Q1 2026, Q4 2025, and Q3 2025 respectively.